Ademi LLP is investigating DecisionPoint (NYSE American: DPSI) for possible breaches of fiduciary duty and other violations of law in its transaction with Graham Partners.
In the transaction, DecisionPoint stockholders will receive only $10.22 in cash per share. The transaction agreement unreasonably limits competing transactions for DecisionPoint by imposing a significant penalty if DecisionPoint accepts a competing bid. DecisionPoint insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of DecisionPoint’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.